434 related articles for article (PubMed ID: 29290818)
1. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract][Full Text] [Related]
2. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M
Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480
[No Abstract] [Full Text] [Related]
3. miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway.
Kong L; Wei Q; Hu X; Chen L; Li J
Med Sci Monit Basic Res; 2019 Feb; 25():53-62. PubMed ID: 30773530
[TBL] [Abstract][Full Text] [Related]
4. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.
Wang Y; Chan DW; Liu VW; Chiu P; Ngan HY
Clin Cancer Res; 2010 May; 16(9):2529-39. PubMed ID: 20388850
[TBL] [Abstract][Full Text] [Related]
5. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.
Liang H; Liu M; Yan X; Zhou Y; Wang W; Wang X; Fu Z; Wang N; Zhang S; Wang Y; Zen K; Zhang CY; Hou D; Li J; Chen X
J Biol Chem; 2015 Jan; 290(2):926-40. PubMed ID: 25391651
[TBL] [Abstract][Full Text] [Related]
6. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
[TBL] [Abstract][Full Text] [Related]
7. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
[TBL] [Abstract][Full Text] [Related]
8. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
9. E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness.
Cheng FHC; Lin HY; Hwang TW; Chen YC; Huang RL; Chang CB; Yang W; Lin RI; Lin CW; Chen GCW; Mai SY; Lin JMJ; Chuang YM; Chou JL; Kuo LW; Li C; Cheng ASL; Lai HC; Wu SF; Tsai JC; Chan MWY
Cancer Sci; 2019 Mar; 110(3):1085-1095. PubMed ID: 30582655
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
11. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.
Chan DW; Hui WW; Cai PC; Liu MX; Yung MM; Mak CS; Leung TH; Chan KK; Ngan HY
PLoS One; 2012; 7(12):e52578. PubMed ID: 23285101
[TBL] [Abstract][Full Text] [Related]
12. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
13. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
14. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
[TBL] [Abstract][Full Text] [Related]
15. DNM3OS Facilitates Ovarian Cancer Progression by Regulating miR-193a-3p/MAP3K3 Axis.
He L; He G
Yonsei Med J; 2021 Jun; 62(6):535-544. PubMed ID: 34027641
[TBL] [Abstract][Full Text] [Related]
16. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
[TBL] [Abstract][Full Text] [Related]
17. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
18. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C
Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
